Fungal diseases kill more than 1.5 million and affect over a billion people. However, they are still a neglected topic by public health authorities even though most deaths from fungal diseases are avoidable. Serious fungal infections occur as a consequence of other health problems including asthma, AIDS, cancer, organ transplantation and corticosteroid therapies. Early accurate…
Journal of Fungi Template
Write in a clean editor, then format for Journal of Fungi in one click — DocuGuru applies the official MDPI template with numbered references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
About the Journal of Fungi format
Journal of Fungi is a peer-reviewed journal published by MDPI, covering Plant Pathogens and Fungal Diseases, Antifungal resistance and susceptibility, Fungal Infections and Studies. Over its lifetime it has published 6,710 papers, which have received 122,175 citations.
| Publisher | MDPI |
|---|---|
| Reference style | Numbered (MDPI) Numbered — [1], [2] in the text 1. Smith, A.; Jones, B.; Lee, C. A Representative Article Title. Journal of Fungi 2023, 12, 45–58.
Formats any DOI in Journal of Fungi style. No sign-up. |
| Abbreviation (ISO-4) | J. Fungi |
| Publishes research in | Plant Pathogens and Fungal Diseases Antifungal resistance and susceptibility Fungal Infections and Studies Mycorrhizal Fungi and Plant Interactions Fungal Biology and Applications |
| ISSN | 2309-608X |
| Citation impact (2-yr) | 3.93 |
| h-index | 112 |
| i10-index | 3,183 |
| Article processing charge | $2,165 |
| Open access | Yes — indexed in DOAJ |
| Top institutions publishing here | Chinese Academy of Sciences |
| Journal website | www.mdpi.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Papers published in Journal of Fungi per year
Citation impact of Journal of Fungi by publication year
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Most-cited papers in Journal of Fungi
Mucormycosis is an angio-invasive fungal infection, associated with high morbidity and mortality. A change in the epidemiology of mucormycosis has been observed in recent years with the rise in incidence, new causative agents and susceptible population. The rise has been perceived globally, but it is very high in the Asian continent. Though diabetes mellitus overshadow…
Candida albicans is a common commensal fungus that colonizes the oropharyngeal cavity, gastrointestinal and vaginal tract, and healthy individuals’ skin. In 50% of the population, C. albicans is part of the normal flora of the microbiota. The various clinical manifestations of Candida species range from localized, superficial mucocutaneous disorders to invasive diseases that involve multiple…
Mucormycosis is an angioinvasive fungal infection, due to fungi of the order Mucorales. Its incidence cannot be measured exactly, since there are few population-based studies, but multiple studies have shown that it is increasing. The prevalence of mucormycosis in India is about 80 times the prevalence in developed countries, being approximately 0.14 cases per 1000…
Mucormycosis (MCR) has been increasingly described in patients with coronavirus disease 2019 (COVID-19) but the epidemiological factors, presentation, diagnostic certainty, and outcome of such patients are not well described. We review the published COVID-19-associated mucormycosis (CAMCR) cases (total 41) to identify risk factors, clinical features, and outcomes. CAMCR was typically seen in patients with diabetes…